{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:21:04Z","timestamp":1789464064682,"version":"build-2803163510"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["14172MFDS974"],"award-info":[{"award-number":["14172MFDS974"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI15C2854"],"award-info":[{"award-number":["HI15C2854"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1003958"],"award-info":[{"award-number":["NRF-2019R1A2C1003958"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","award":["program year of 2019"],"award-info":[{"award-number":["program year of 2019"]}],"id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222587","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T17:32:04Z","timestamp":1569605524000},"page":"e0222587","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke"],"prefix":"10.1371","volume":"14","author":[{"given":"Sun","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheong A.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Eun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-7584","authenticated-orcid":true,"given":"Kyung-Ok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"issue":"3","key":"pone.0222587.ref001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"AS Go","year":"2014","journal-title":"Circulation"},{"issue":"13","key":"pone.0222587.ref002","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"W Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0222587.ref003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/14712598.2015.1040386","article-title":"Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke","volume":"15","author":"M Gutierrez-Fernandez","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"pone.0222587.ref004","article-title":"Recent Advances in Stem Cell-Based Therapeutics for Stroke","author":"E Napoli","year":"2016","journal-title":"Translational stroke research"},{"issue":"2","key":"pone.0222587.ref005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.59566\/IJBS.2007.3076","article-title":"The immune properties of mesenchymal stem cells","volume":"3","author":"M Castillo","year":"2007","journal-title":"Int J Biomed Sci"},{"issue":"4","key":"pone.0222587.ref006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1254\/jphs.14R10CP","article-title":"Therapeutic potential of human adipose-derived stem cells in neurological disorders","volume":"126","author":"KA Chang","year":"2014","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"pone.0222587.ref007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14712598.6.6.567","article-title":"Adipose-derived stem cells for the regeneration of damaged tissues","volume":"6","author":"AM Parker","year":"2006","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"pone.0222587.ref008","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans","volume":"20","author":"JC Ra","year":"2011","journal-title":"Stem Cells Dev"},{"issue":"2","key":"pone.0222587.ref009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3727\/215517912X647172","article-title":"The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke","volume":"4","author":"OY Bang","year":"2012","journal-title":"Cell Med"},{"issue":"1","key":"pone.0222587.ref010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","article-title":"Neuregulins: functions, forms, and signaling strategies","volume":"284","author":"DL Falls","year":"2003","journal-title":"Exp Cell Res"},{"issue":"1","key":"pone.0222587.ref011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gene.2004.07.029","article-title":"Multiple novel transcription initiation sites for NRG1","volume":"342","author":"V Steinthorsdottir","year":"2004","journal-title":"Gene"},{"issue":"2","key":"pone.0222587.ref012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.11.002","article-title":"Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology","volume":"60","author":"PJ Harrison","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"33","key":"pone.0222587.ref013","doi-asserted-by":"crossref","first-page":"24343","DOI":"10.1074\/jbc.M702953200","article-title":"Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia","volume":"282","author":"W Tan","year":"2007","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0222587.ref014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0959-4388(00)00210-5","article-title":"Neuregulin and ErbB receptor signaling pathways in the nervous system","volume":"11","author":"A Buonanno","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"pone.0222587.ref015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.20.1.429","article-title":"ARIA: A neuromuscular junction neuregulin","volume":"20","author":"GD Fischbach","year":"1997","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"pone.0222587.ref016","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceb.2007.02.008","article-title":"The EGF receptor family: spearheading a merger of signaling and therapeutics","volume":"19","author":"EM Bublil","year":"2007","journal-title":"Curr Opin Cell Biol"},{"issue":"13","key":"pone.0222587.ref017","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","article-title":"The ErbB signaling network: receptor heterodimerization in development and cancer","volume":"19","author":"MA Olayioye","year":"2000","journal-title":"EMBO J"},{"key":"pone.0222587.ref018","first-page":"1","article-title":"The neuregulin-I\/ErbB signaling system in development and disease","volume":"190","author":"S. Britsch","year":"2007","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"4","key":"pone.0222587.ref019","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/342734","article-title":"Neuregulin 1 and susceptibility to schizophrenia","volume":"71","author":"H Stefansson","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"1\u20132","key":"pone.0222587.ref020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0165-5728(99)00201-5","article-title":"Neuregulin and erbB receptor expression in normal and diseased human white matter","volume":"100","author":"B Cannella","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"5","key":"pone.0222587.ref021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/mcne.2000.0894","article-title":"Closed head injury induces up-regulation of ErbB-4 receptor at the site of injury","volume":"16","author":"S Erlich","year":"2000","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"pone.0222587.ref022","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.21-04-01257.2001","article-title":"Regulation of neuregulin expression in the injured rat brain and cultured astrocytes","volume":"21","author":"Y Tokita","year":"2001","journal-title":"J Neurosci"},{"issue":"3","key":"pone.0222587.ref023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(02)01126-6","article-title":"Neuregulin expression after focal stroke in the rat","volume":"334","author":"MW Parker","year":"2002","journal-title":"Neurosci Lett"},{"issue":"4","key":"pone.0222587.ref024","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.jcbfm.9600212","article-title":"Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke","volume":"26","author":"Z Xu","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20132","key":"pone.0222587.ref025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2015.06.055","article-title":"Spatio-temporal assessment of the neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI","volume":"357","author":"S Wang","year":"2015","journal-title":"J Neurol Sci"},{"issue":"3","key":"pone.0222587.ref026","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2005.01.027","article-title":"Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression","volume":"19","author":"Z Xu","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"5","key":"pone.0222587.ref027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10059-010-0137-5","article-title":"Secretion of EGF-like domain of heregulinbeta promotes axonal growth and functional recovery of injured sciatic nerve","volume":"30","author":"I Joung","year":"2010","journal-title":"Mol Cells"},{"issue":"1","key":"pone.0222587.ref028","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.expneurol.2008.03.017","article-title":"Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke","volume":"212","author":"KO Cho","year":"2008","journal-title":"Exp Neurol"},{"issue":"2","key":"pone.0222587.ref029","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/1673-5374.177739","article-title":"Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain","volume":"11","author":"S Ryu","year":"2016","journal-title":"Neural Regen Res"},{"issue":"Suppl 3","key":"pone.0222587.ref030","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.5213\/inj.1836220.110","article-title":"Therapeutic Potential of Human Turbinate-Derived Mesenchymal Stem Cells in Experimental Acute Ischemic Stroke","volume":"22","author":"H Lim","year":"2018","journal-title":"Int Neurourol J"},{"issue":"4","key":"pone.0222587.ref031","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"J Chen","year":"2001","journal-title":"Stroke"},{"issue":"2","key":"pone.0222587.ref032","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jcbfm.2011.150","article-title":"Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives","volume":"32","author":"M Zille","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"pone.0222587.ref033","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.jcbfm.9600273","article-title":"Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector","volume":"26","author":"MZ Zhao","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"pone.0222587.ref034","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbrc.2004.07.149","article-title":"Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke","volume":"322","author":"ZF Xu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"4\u20135","key":"pone.0222587.ref035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3727\/096368914X678409","article-title":"The Use of ADSCs as a Treatment for Chronic Stroke","volume":"23","author":"TM Chan","year":"2014","journal-title":"Cell Transplant"},{"issue":"2","key":"pone.0222587.ref036","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0014-4886(03)00089-X","article-title":"Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats","volume":"183","author":"SK Kang","year":"2003","journal-title":"Exp Neurol"},{"key":"pone.0222587.ref037","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fneur.2019.00235","article-title":"Combined Adipose Tissue-Derived Mesenchymal Stem Cell Therapy and Rehabilitation in Experimental Stroke","volume":"10","author":"J Mu","year":"2019","journal-title":"Front Neurol"},{"issue":"2","key":"pone.0222587.ref038","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymthe.2003.10.012","article-title":"BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model","volume":"9","author":"K Kurozumi","year":"2004","journal-title":"Mol Ther"},{"issue":"1","key":"pone.0222587.ref039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2005.06.062","article-title":"I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat","volume":"136","author":"T Nomura","year":"2005","journal-title":"Neuroscience"},{"key":"pone.0222587.ref040","doi-asserted-by":"crossref","first-page":"129145","DOI":"10.1155\/2014\/129145","article-title":"Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model","volume":"2014","author":"CH Jeong","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"pone.0222587.ref041","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1440-1789.2002.00450.x","article-title":"Ischemic rat brain extracts induce human marrow stromal cell growth factor production","volume":"22","author":"X Chen","year":"2002","journal-title":"Neuropathology"},{"issue":"21","key":"pone.0222587.ref042","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.18632\/oncotarget.2420","article-title":"RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells","volume":"5","author":"A De Luca","year":"2014","journal-title":"Oncotarget"},{"issue":"Pt 10","key":"pone.0222587.ref043","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awl207","article-title":"Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia","volume":"129","author":"H Liu","year":"2006","journal-title":"Brain"},{"issue":"1","key":"pone.0222587.ref044","first-page":"8","article-title":"Protective Effect of Ad-VEGF-Bone Mesenchymal Stem Cells on Cerebral Infarction","volume":"26","author":"B Chen","year":"2016","journal-title":"Turk Neurosurg"},{"issue":"5","key":"pone.0222587.ref045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11596-012-1025-3","article-title":"Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2","volume":"32","author":"T Lai","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"12","key":"pone.0222587.ref046","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1161\/01.STR.0000190006.88896.d3","article-title":"Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats","volume":"36","author":"N Ikeda","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"pone.0222587.ref047","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1227\/01.NEU.0000290907.30814.42","article-title":"Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia","volume":"61","author":"Y Miki","year":"2007","journal-title":"Neurosurgery"},{"issue":"1","key":"pone.0222587.ref048","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainres.2006.03.007","article-title":"Neuroprotective effects of neuregulin-1 in rat models of focal cerebral ischemia","volume":"1087","author":"WP Guo","year":"2006","journal-title":"Brain Res"},{"issue":"7","key":"pone.0222587.ref049","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neurobiolaging.2003.10.012","article-title":"Neuregulin-1 reduces ischemia-induced brain damage in rats","volume":"25","author":"WC Shyu","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"3","key":"pone.0222587.ref050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2004.11.039","article-title":"Upregulation of erbB receptors in rat brain after middle cerebral arterial occlusion","volume":"375","author":"Z Xu","year":"2005","journal-title":"Neurosci Lett"},{"issue":"4","key":"pone.0222587.ref051","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuron.2007.03.028","article-title":"The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity","volume":"54","author":"B Li","year":"2007","journal-title":"Neuron"},{"key":"pone.0222587.ref052","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2015.08.047","article-title":"Neuregulin 1 protects against ischemic brain injury via ErbB4 receptors by increasing GABAergic transmission","volume":"307","author":"YF Guan","year":"2015","journal-title":"Neuroscience"},{"issue":"50","key":"pone.0222587.ref053","doi-asserted-by":"crossref","first-page":"21818","DOI":"10.1073\/pnas.1010669107","article-title":"ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation","volume":"107","author":"YJ Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0222587.ref054","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuron.2007.04.009","article-title":"Neuregulin-1 enhances depolarization-induced GABA release","volume":"54","author":"RS Woo","year":"2007","journal-title":"Neuron"},{"key":"pone.0222587.ref055","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00004","article-title":"ErbB1-4-dependent EGF\/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease","volume":"7","author":"Y Iwakura","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"pone.0222587.ref056","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3892\/mmr.2016.5325","article-title":"Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model","volume":"14","author":"Z Yang","year":"2016","journal-title":"Mol Med Rep"},{"issue":"4","key":"pone.0222587.ref057","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jnc.12109","article-title":"Neuregulin 1 up-regulates the expression of nicotinic acetylcholine receptors through the ErbB2\/ErbB3-PI3K-MAPK signaling cascade in adult autonomic ganglion neurons","volume":"124","author":"HG Kim","year":"2013","journal-title":"J Neurochem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T05:09:20Z","timestamp":1721797760000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222587"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Pignataro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222587","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}